Expression of mouse agrin in normal, denervated and dystrophic muscle

Neuromuscular Disorders

Volumn 13, Issue 5, 2003, Pages 408-415

  Eusebio, Alexander ^a   Oliveri, Filippo ^a   Barzaghi, Patrizia ^a   Ruegg, Markus A ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Congenital muscular dystrophy; dyW; Dystrophin; Laminin; Mouse; 7 integrin

Indexed keywords

AGRIN; POLYCLONAL ANTISERUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ELECTRIC ACTIVITY; MOUSE; MUSCLE DENERVATION; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCIATIC NERVE; TISSUE DISTRIBUTION; TISSUE LEVEL; WILD TYPE;

EID: 0037835964     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(03)00036-1     Document Type: Article

References (57)

1. Nitkin R.M., Smith M.A., Magill C., et al. Identification of agrin, a synaptic organizing protein from Torpedo electric organ. J Cell Biol. 105:1987;2471-2478.
2. Gautam M., Noakes P.G., Moscoso L., et al. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell. 85:1996;525-535.
3. Lin W., Burgess R.W., Dominguez B., Pfaff S.L., Sanes J.R., Lee K.F. Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse. Nature. 410:2001;1057-1064.
4. McMahan U.J. The agrin hypothesis. Cold Spring Harb Symp Quant Biol. 55:1990;407-418.
5. Burgess R.W., Skarnes W.C., Sanes J.R. Agrin isoforms with distinct amino termini. Differential expression, localization, and function. J Cell Biol. 151:2000;41-52.
6. Neumann F.R., Bittcher G., Annies M., Schumacher B., Kroger S., Ruegg M.A. An alternative amino-terminus expressed in the central nervous system converts agrin to a type II transmembrane protein. Mol Cell Neurosci. 17:2001;208-225.
7. Denzer A.J., Brandenberger R., Gesemann M., Chiquet M., Ruegg M.A. Agrin binds to the nerve-muscle basal lamina via laminin. J Cell Biol. 137:1997;671-683.
8. Denzer A.J., Schulthess T., Fauser C., et al. Electron microscopic structure of agrin and mapping of its binding site in laminin-1. EMBO J. 17:1998;335-343.
9. Kammerer R.A., Schulthess T., Landwehr R., et al. Interaction of agrin with laminin requires a coiled-coil conformation of the agrin-binding site within the laminin γ1 chain. EMBO J. 18:1999;6762-6770.
10. Ruegg M.A., Bixby J.L. Agrin orchestrates synaptic differentiation at the vertebrate neuromuscular junction. Trends Neurosci. 21:1998;22-27.
11. Hoch W., Ferns M., Campanelli J.T., Hall Z.W., Scheller R.H. Developmental regulation of highly active alternatively spliced forms of agrin. Neuron. 11:1993;479-490.
12. Groffen A.J., Ruegg M.A., Dijkman H., et al. Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. J Histochem Cytochem. 46:1998;19-27.
13. Burgess R.W., Nguyen Q.T., Son Y.J., Lichtman J.W., Sanes J.R. Alternatively spliced isoforms of nerve- and muscle-derived agrin: their roles at the neuromuscular junction. Neuron. 23:1999;33-44.
14. Gesemann M., Brancaccio A., Schumacher B., Ruegg M.A. Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue. J Biol Chem. 273:1998;600-605.
15. Colognato H., Yurchenco P.D. Form and function: the laminin family of heterotrimers. Dev Dyn. 218:2000;213-234.
16. Libby R.T., Champliaud M.F., Claudepierre T., et al. Laminin expression in adult and developing retinae: evidence of two novel CNS laminins. J Neurosci. 20:2000;6517-6528.
17. Patton B.L., Miner J.H., Chiu A.Y., Sanes J.R. Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice. J Cell Biol. 139:1997;1507-1521.
18. Ibraghimov-Beskrovnaya O., Ervasti J.M., Leveille C.J., Slaughter C.A., Sernett S.W., Campbell K.P. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 355:1992;696-702.
19. Ervasti J.M., Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol. 122:1993;809-823.
20. Henry M.D., Campbell K.P. Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton. Curr Opin Cell Biol. 8:1996;625-631.
21. Allamand V., Campbell K.P. Animal models for muscular dystrophy: valuable tools for the development of therapies. Hum Mol Genet. 9:2000;2459-2467.
22. Brockington M., Blake D.J., Prandini P., et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet. 69:2001;1198-1209.
23. Michele D.E., Barresi R., Kanagawa M., et al. Post-translational disruption of dystroglycan ligand interactions in congenital muscular dystrophies. Nature. 418:2002;417-421.
24. von der Mark H., Durr J., Sonnenberg A., von der Mark K., Deutzmann R., Goodman S.L. Skeletal myoblasts utilize a novel beta 1-series integrin and not alpha 6 beta 1 for binding to the E8 and T8 fragments of laminin. J Biol Chem. 266:1991;23593-23601.
25. Kramer R.H., Vu M.P., Cheng Y.F., Ramos D.M., Timpl R., Waleh N. Laminin-binding integrin alpha 7 beta 1: functional characterization and expression in normal and malignant melanocytcs. Cell Regul. 2:1991;805-817.
26. Yao C.C., Ziober B.L., Squillace R.M., Kramer R.H. Alpha7 integrin mediates cell adhesion and migration on specific laminin isoforms. J Biol Chem. 271:1996;25598-25603.
27. Ocalan M., Goodman S.L., Kuhl U., Hauschka S.D., von der Mark K. Laminin alters cell shape and stimulates motility and proliferation of murine skeletal myoblasts. Dev Biol. 125:1988;158-167.
28. Goodman S.L., Risse G., von der Mark K. The E8 subfragment of laminin promotes locomotion of myoblasts over extracellular matrix. J Cell Biol. 109:1989;799-809.
29. Song W.K., Wang W., Foster R.F., Bielser D.A., Kaufman S.J. H36-alpha 7 is a novel integrin alpha chain that is developmentally regulated during skeletal myogenesis. J Cell Biol. 117:1992;643-657.
30. Bao Z.Z., Lakonishok M., Kaufman S., Horwitz A.F. Alpha 7 beta 1 integrin is a component of the myotendinous junction on skeletal muscle. J Cell Sci. 106:1993;579-589.
31. Martin P.T., Kaufman S.J., Kramer R.H., Sanes J.R. Synaptic integrins in developing, adult, and mutant muscle: selective association of α1, α7A, and α7B integrins with the neuromuscular junction. Dev Biol. 174:1996;125-139.
32. Mayer U., Saher G., Fassler R., et al. Absence of integrin α7 causes a novel form of muscular dystrophy. Nat Genet. 17:1997;318-323.
33. Hayashi Y.K., Chou F.L., Engvall E., et al. Mutations in the integrin alpha7 gene cause congenital myopathy. Nat Genet. 19:1998;94-97.
34. Burkin D.J., Wallace G.Q., Nicol K.J., Kaufman D.J., Kaufman S.J. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice. J Cell Biol. 152:2001;1207-1218.
35. Moll J., Barzaghi P., Lin S., et al. An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. Nature. 413:2001;302-307.
36. Miyagoe-Suzuki Y., Nakagawa M., Takeda S. Merosin and congenital muscular dystrophy. Microsc Res Tech. 48:2000;181-191.
37. Kohfeldt E., Maurer P., Vannahme C., Timpl R. Properties of the extracellular calcium binding module of the proteoglycan testican. FEBS Lett. 414:1997;557-561.
38. Cooper H., Paterson Y. Production of antibodies. Coligan J., Kruisbeek A., Margulies D., Shevach E., Strober W. Current protocols in immunology. 1995;241-249 John Wiley & Sons, New York.
39. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
40. Denzer A.J., Gesemann M., Schumacher B., Ruegg M.A. An amino-terminal extension is required for the secretion of chick agrin and its binding to extracellular matrix. J Cell Biol. 131:1995;1547-1560.
41. Kuang W., Xu H., Vachon P.H., et al. Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models. J Clin Invest. 102:1998;844-852.
42. Bulfield G., Siller W.G., Wight P.A., Moore K.J. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA. 81:1984;1189-1192.
43. Turney S.G., Culican S.M., Lichtman J.W. A quantitative fluorescence-imaging technique for studying acetylcholine receptor turnover at neuromuscular junctions in living animals. J Neurosci Methods. 64:1996;199-208.
44. Tolmachova T., Simpson K., Huxley C. Analysis of a YAC with human telomeres and oriP from Epstein-Barr virus in yeast and 293 cells. Nucleic Acids Res. 27:1999;3736-3744.
45. Raats C.J., Bakker M.A., Hoch W., et al. Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies. J Biol Chem. 273:1998;17832-17838.
46. Godfrey E.W., Siebenlist R.E., Wallskog P.A., Walters L.M., Bolender D.L., Yorde D.E. Basal lamina components are concentrated in premuscle masses and at early acetylcholine receptor clusters in chick embryo hindlimb muscles. Dev Biol. 130:1988;471-486.
47. Draeger A., Weeds A.G., Fitzsimons R.B. Primary, secondary and tertiary myotubes in developing skeletal muscle: a new approach to the analysis of human myogenesis. J Neurol Sci. 81:1987;19-43.
48. Narusawa M., Fitzsimons R.B., Izumo S., Nadal-Ginard B., Rubinstein N.A., Kelly A.M. Slow myosin in developing rat skeletal muscle. J Cell Biol. 104:1987;447-459.
49. Ohlendieck K., Campbell K.P. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol. 115:1991;1685-1694.
50. Martin P.T., Sanes J.R. Integrins mediate adhesion to agrin and modulate agrin signaling. Development. 124:1997;3909-3917.
51. Burkin D.J., Gu M., Hodges B.L., Campanelli J.T., Kaufman S.J. A functional role for specific spliced variants of the alpha7beta1 integrin in acetylcholine receptor clustering. J Cell Biol. 143:1998;1067-1075.
52. Burkin D.J., Kim J.E., Gu M., Kaufinan S.J. Laminin and alpha7beta1 integrin regulate agrin-induced clustering of acetylcholine receptors. J Cell Sci. 113:2000;2877-2886.
53. Bixby J.L., Baerwald-De La Torre K., Wang C., Rathjen F.G., Ruegg M.A. A neuronal inhibitory domain in the N-terminal half of agrin. J Neurobiol. 50:2002;164-179.
54. Duclert A., Changeux J.P. Acetylcholine receptor gene expression at the developing neuromuscular junction. Physiol Rev. 75:1995;339-368.
55. Schaeffer L., de Kerchove d'Exaerde A., Changeux J.P. Targeting transcription to the neuromuscular synapse. Neuron. 31:2001;15-22.
56. Lieth E., Cardasis C.A., Fallon J.R. Muscle-derived agrin in cultured myotubes: expression in the basal lamina and at induced acetylcholine receptor clusters. Dev Biol. 149:1992;41-54.
57. Sicinski P., Geng Y., Ryder-Cook A.S., Barnard E.A., Darlison M.G., Barnard P.J. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science. 244:1989;1578-1580.